Palladium-Catalyzed Enantioselective Cross-Coupling: Atroposelective Suzuki and Asymmetric Heck

June 12, 2026 Metal Catalysis, Science palladium, asymmetric, cross-coupling, Suzuki, Heck, atroposelective, BINAP, chiral

While most palladium cross-coupling uses achiral phosphines, a growing family of enantioselective Pd-catalyzed reactions uses chiral diphosphines to construct stereocenters and axially chiral biaryls. These transformations — atroposelective Suzuki–Miyaura coupling, asymmetric Heck cyclization, and enantioselective allylic substitution — are increasingly important in drug discovery as axial chirality appears in more clinical candidates.

Atroposelective Suzuki–Miyaura Coupling

Coupling of an ortho-substituted aryl halide with an ortho-substituted arylboronic acid generates a biaryl axis whose rotation is hindered by the ortho groups. A chiral Pd catalyst — typically (BINAP)Pd or (SEGPHOS)Pd — controls which atropisomer forms, giving enantiomerically enriched axially chiral biaryls directly. This is the most efficient route to BINOL analogs, MOP ligands, and axially chiral pharmacophores.

Asymmetric Heck Reaction

The intramolecular asymmetric Heck cyclization, pioneered by Shibasaki and Overman, constructs quaternary stereocenters and fused ring systems using (BINAP)Pd or (DIOP)Pd catalysts. It is a key step in several natural product total syntheses, including the Overman synthesis of (−)-morphine and related alkaloids.

Enantioselective Allylic Substitution

The Trost (DACH-phenyl)Pd system is the dominant platform for asymmetric allylic alkylation and amination (covered in a dedicated article). For substrates where the Trost ligand underperforms, (BINAP)Pd and (SEGPHOS)Pd offer complementary selectivity profiles.

Catalyst Forms

  • (BINAP)PdCl₂ — bench-stable precatalyst for atroposelective coupling.
  • In situ generation — Pd₂(dba)₃ + chiral diphosphine for rapid screening.
  • Cationic Pd — [Pd(allyl)(diphosphine)]⁺BF₄⁻ for Heck and allylic substitution.

Frontier Directions

Recent work has extended enantioselective Pd catalysis to: (1) C(sp³)–C(sp³) coupling via Ni/Pd dual catalysis, (2) atroposelective C–N coupling for axially chiral anilines, and (3) dynamic kinetic asymmetric transformations of racemic electrophiles. The growing importance of axial chirality in medicinal chemistry ensures continued expansion of chiral Pd cross-coupling methodology.